Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 7, 2015, Pages 2139-2144

  Gaglia, Jason L ^a   Harisinghani, Mukesh ^b,c   Aganj, Iman ^c   Wojtkiewicz, Gregory R ^b,c   Hedgire, Sandeep ^b,c   Benoist, Christophe ^d,e   Mathis, Diane ^d,e   Weissleder, Ralph ^b,c  

^a JOSLIN DIABETES CENTER   (United States)

^b Center for Systems Biology   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Autoimmune diabetes; Insulitis; Magnetic resonance imaging; Nanoparticle; Pancreas

Indexed keywords

FERUMOXYTOL; HEMOGLOBIN A1C; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREATITIS; PRIORITY JOURNAL; YOUNG ADULT; ADOLESCENT; INFLAMMATION; PATHOPHYSIOLOGY; PILOT STUDY;

ADOLESCENT; DIABETES MELLITUS, TYPE 1; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; PANCREAS; PILOT PROJECTS;

EID: 84923172399     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1424993112     Document Type: Article

References (37)

1. Herold KC, Vignali DA, Cooke A, Bluestone JA (2013) Type 1 diabetes: Translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol 13(4): 243-256.
2. Achenbach P, et al. (2013) Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia 56(7):1615-1622.
3. Verge CF, et al. (1996) Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45(7): 926-933.
4. Sosenko JM, et al.; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group (2013) The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients. Diabetes Care 36(9):2615-2620.
5. Ziegler AG, et al. (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309(23):2473-2479.
6. Campbell-Thompson ML, et al. (2013) The diagnosis of insulitis in human type 1 diabetes. Diabetologia 56(11):2541-2543.
7. In't Veld P (2011) Insulitis in human type 1 diabetes: The quest for an elusive lesion. Islets 3(4):131-138.
8. Pugliese A, et al. (2014) New insight on human type 1 diabetes biology: nPOD and nPOD-transplantation. Curr Diab Rep 14(10):530.
9. Papaccio G (1993) Insulitis and islet microvasculature in type 1 diabetes. Histol Histopathol 8(4):751-759.
10. De Paepe ME, Corriveau M, Tannous WN, Seemayer TA, Colle E (1992) Increased vascular permeability in pancreas of diabetic rats: Detection with high resolution protein A-gold cytochemistry. Diabetologia 35(12):1118-1124.
11. Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R (2004) Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci USA 101(34): 12634-12639.
12. Signore A, et al. (1996) In vivo measurement of immunoglobulin accumulation in the pancreas of recent onset type 1 diabetic patients. Clin Exp Rheumatol 14(Suppl 15): S41-S45.
13. Jansen A, et al. (1994) Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 43(5):667-675.
14. Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H (1989) Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia 32(2):126-134.
15. Fu W, Wojtkiewicz G, Weissleder R, Benoist C, Mathis D (2012) Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging. Nat Immunol 13(4):361-368.
16. Turvey SE, et al. (2005) Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest 115(9):2454-2461.
17. Gaglia JL, et al. (2011) Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest 121(1):442-445.
18. Landry R, Jacobs PM, Davis R, Shenouda M, Bolton WK (2005) Pharmacokinetic study of ferumoxytol: A new iron replacement therapy in normal subjects and hemodialysis patients. Am J Nephrol 25(4):400-410.
19. Wood JC, et al. (2005) MRI R2 and R2∗ mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106(4):1460-1465.
20. Altobelli E, et al. (1998) Size of pancreas in children and adolescents with type I (insulin-dependent) diabetes. J Clin Ultrasound 26(8):391-395.
21. Goda K, et al. (2001) Pancreatic volume in type 1 and type 2 diabetes mellitus. Acta Diabetol 38(3):145-149.
22. Williams AJ, Chau W, Callaway MP, Dayan CM (2007) Magnetic resonance imaging: A reliable method for measuring pancreatic volume in Type 1 diabetes. Diabet Med 24(1):35-40.
23. Fischl B, Sereno MI, Dale AM (1999) Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9(2):195-207.
24. Alanentalo T, et al. (2010) Quantification and three-dimensional imaging of the insulitis-induced destruction of beta-cells in murine type 1 diabetes. Diabetes 59(7): 1756-1764.
25. In't Veld P (2014) Insulitis in human type 1 diabetes: A comparison between patients and animal models. Semin Immunopathol 36(5):569-579.
26. McCormack PL (2012) Ferumoxytol: In iron deficiency anaemia in adults with chronic kidney disease. Drugs 72(15):2013-2022.
27. Lu M, Cohen MH, Rieves D, Pazdur R (2010) FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am J Hematol 85(5): 315-319.
28. Herold KC, et al.; AbATE Study Team (2013) Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: Metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes 62(11):3766-3774.
29. Petersen JS, et al.; The Canadian-European Randomized Control Trial Group (1994) Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. Diabetes 43(11): 1291-1296.
30. In't Veld P, et al. (2010) Beta-cell replication is increased in donor organs from young patients after prolonged life support. Diabetes 59(7):1702-1708.
31. Harisinghani M, Ross RW, Guimaraes AR, Weissleder R (2007) Utility of a new bolusinjectable nanoparticle for clinical cancer staging. Neoplasia 9(12):1160-1165.
32. Weissleder R, Nahrendorf M, Pittet MJ (2014) Imaging macrophages with nanoparticles. Nat Mater 13(2):125-138.
33. Reuter M, Rosas HD, Fischl B (2010) Highly accurate inverse consistent registration: a Robust approach. Neuroimage 53(4):1181-1196.
34. Vercauteren T, Pennec X, Perchant A, Ayache A (2007) Diffeomorphic demons using ITK's finite difference solver hierarchy. The Insight Journal - 2007 MICCAI Open Science Workshop. Available at hdl.handle.net/1926/510. Accessed January 20, 2015.
35. Kozinskaa D, Tretiakb OJ, Nissanovb J, Ozturkb C (1997) Multidimensional alignment using the euclidean distance transform. Graph Models Image Proc 59(6):373-387.
36. Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9(2):179-194.
37. Fischl B (2012) Free Surfer. Neuroimage 62(2):774-781.